AIM
CLB icon

Aster Investment Management’s Core Laboratories CLB Stock Holding History

Aster Investment Management’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q2 		$34.4M Buy
+227,000
New +$32.2M 1.28% 31

Other funds holding CLB

CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
VAM
Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
WI
WHV Investments San Francisco, California $187M AUM 14.29% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Aster Investment Management's CLB Position: Q2 2013 in Review

Aster Investment Management opened a new position in Core Laboratories (CLB) in Q2 2013: 227,000 shares worth $34.4M. The stake represents 1.28% of the portfolio and ranks #31 among its holdings.

290 funds tracked by Wall St. Rank hold CLB as of Q2 2013.

  • Aster Investment Management held 227,000 shares of Core Laboratories worth $34.4M as of Q2 2013.
  • Core Laboratories was a new Aster Investment Management position in Q2 2013.
  • Core Laboratories made up 1.28% of Aster Investment Management's portfolio in Q2 2013, its #31 holding.
  • 290 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2013.

Based on Aster Investment Management's 13F filing for Q2 2013, filed 29 Jul 2013.